Complete Monthly Cost Breakdown: What You'll Actually Pay
Understanding Mounjaro vs Ozempic vs Wegovy Monthly Pricing in the UK
When comparing Mounjaro vs Ozempic vs Wegovy monthly costs, it's essential to understand that these are distinct prescription-only medicines with different pricing structures. Ozempic is licensed exclusively for type 2 diabetes management, making direct cost comparisons for weight management inappropriate and potentially misleading. Wegovy (semaglutide) operates as a GLP-1 receptor agonist specifically licensed for weight management, whilst Mounjaro (tirzepatide) functions as a dual GIP and GLP-1 receptor agonist.
The monthly investment for Mounjaro vs Ozempic vs Wegovy varies significantly based on dose requirements, availability, and licensing status. At EverydayMeds, we focus exclusively on properly licensed weight management treatments, ensuring you receive appropriate clinical oversight alongside your monthly prescription supply. Our transparent pricing eliminates the guesswork often associated with private weight management costs across the UK.
Wegovy Monthly Pricing Structure and Bundle Savings
Your monthly Wegovy costs follow a predictable escalation pattern designed to optimise tolerability and effectiveness. Starting at £79.99 for the 0.25mg dose (weeks 1-4), costs progress to £94.99 for 0.5mg, £99.99 for 1mg, £139.99 for 1.7mg, and £209.99 for the maintenance 2.4mg dose. New customers apply code FIRST40 at checkout, whilst returning customers use DOSE25, with both codes already factored into these final prices.
Our Getting Started bundles provide convenient multi-month supplies, with the Intro Duo (0.25mg & 0.5mg) available for £169.99, covering your first two months of treatment. The Ultimate Stability Trio offers three months of maintenance 2.4mg supply for £649.99, ensuring uninterrupted treatment without monthly reordering concerns. This approach helps when comparing Mounjaro vs Ozempic vs Wegovy long-term affordability.
Clinical Evidence Supporting Mounjaro vs Ozempic vs Wegovy Effectiveness
In clinical trials, patients taking Wegovy alongside diet and exercise achieved significant weight management outcomes, with the STEP 1 trial showing approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The STEP programme demonstrated consistent results across different patient populations, including those with type 2 diabetes.
When evaluating Mounjaro vs Ozempic vs Wegovy clinical data, it's important to note that direct head-to-head comparisons aren't available due to different trial designs and patient populations. Both Wegovy and Mounjaro have shown promising results in their respective clinical programmes, and both are available from EverydayMeds where your prescriber can help determine which treatment aligns with your clinical profile.
How Wegovy Works: GLP-1 Mechanism for Weight Management
Wegovy functions as a GLP-1 receptor agonist, mimicking a natural fullness hormone that regulates appetite and food intake. This mechanism helps reduce appetite whilst promoting feelings of fullness after smaller meals, potentially reducing food cravings by working on brain appetite centres. The once-weekly injection maintains consistent therapeutic levels throughout the week, supporting sustainable eating pattern changes. Unlike traditional weight management approaches, Wegovy addresses the biological drivers of appetite regulation rather than relying solely on willpower. This physiological approach, when combined with a reduced-calorie diet and increased physical activity, creates the foundation for meaningful weight management outcomes.
Streamlined Ordering Process: From Assessment to Delivery
Our efficient process begins with a comprehensive 3-minute online clinical assessment, capturing your medical history, current medications, and weight management goals. Qualified prescribers review your assessment within 3 working days as standard, or within 24 hours using our express service for faster treatment initiation. Once approved, your Wegovy prescription ships via next-day delivery using temperature-controlled cold-chain logistics to maintain medication integrity. Our GPhC-registered pharmacy (#9012878) ensures all prescriptions meet UK regulatory standards before dispatch. Regular follow-up assessments monitor your progress and adjust treatment as needed, maintaining clinical oversight throughout your weight management journey.
Storage Requirements and Practical Considerations
Wegovy requires refrigerated storage at 2-8°C before first use, offering a significant practical advantage with up to 6 weeks room temperature stability below 30°C once removed from the fridge. This extended room temperature storage provides greater flexibility compared to Mounjaro's 21-day room temperature limit, particularly beneficial for travel or lifestyle considerations. The FlexTouch pen design ensures accurate dose delivery throughout the mandatory escalation schedule, preventing dose-skipping that could compromise treatment effectiveness. Each pen contains four doses of the same strength, requiring monthly replacements as you progress through the escalation phases. Proper storage maintains medication potency whilst the user-friendly pen design supports treatment adherence across all dose levels.
Long-term Cost Planning for Mounjaro vs Ozempic vs Wegovy Treatment
Annual cost planning becomes crucial when comparing Mounjaro vs Ozempic vs Wegovy for sustained weight management success. Your first year includes 16 weeks of dose escalation (costing approximately £514.96) followed by maintenance dosing at £209.99 monthly. This creates an annual maintenance cost of approximately £2,519.88 once established on the 2.4mg dose, representing a significant but potentially transformative health investment.
Long-term budgeting should account for the chronic nature of weight management, with clinical evidence suggesting continued treatment maintains achieved weight loss. Our bundle pricing and loyalty discount codes help manage these ongoing costs, whilst the STEP 1 extension data indicates that stopping treatment typically results in weight regain, emphasising the importance of sustained therapy planning when evaluating Mounjaro vs Ozempic vs Wegovy lifetime costs.
Start Your Weight Management Journey with Transparent Pricing
EverydayMeds eliminates pricing uncertainty that often accompanies private weight management treatment across the UK. Our clear monthly costs, reliable supply chain, and clinical oversight provide the foundation for successful long-term weight management planning. Use code FIRST40 as a new customer or DOSE25 for returning patients, with both codes applied at checkout to reach our published prices. Begin with our comprehensive clinical assessment at https://everydaymeds.co.uk/collections/wegovy and receive expert guidance on whether Wegovy aligns with your weight management goals. Your investment in health deserves transparent, professional support backed by our GPhC registration #9012878 and clinical excellence.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
